Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 28, 2004 12:59 ET | Source: Gardant Pharmaceuticals, Inc.

Bioaccelerate Portfolio Company Inncardio Inc. Enters into Licence and Co-development Agreement for INC 105 with the University of Strathclyde

NEW YORK, Sept. 28, 2004 (PRIMEZONE) -- Bioaccelerate Holdings, Inc. (OTCBB:BACL) a pharmaceutical development organization today announced that one of its portfolio companies, Inncardio Inc., a...
September 28, 2004 12:01 ET | Source: Gardant Pharmaceuticals, Inc.

Bioaccelerate Portfolio Company Inncardio Inc. Enters into Licence and Co-development Agreement for INC 105 with the University of Strathclyde

NEW YORK, Sept. 28, 2004 (PRIMEZONE) -- Bioaccelerate Holdings, Inc. (OTCBB:BACL) a pharmaceutical development organization today announced that one of its portfolio companies, Inncardio Inc., a...
August 12, 2004 12:16 ET | Source: Gardant Pharmaceuticals, Inc.

UPDATE: Bioaccelerate Portfolio Company Enhance Biotech to Merge with Privately-Held Ardent Pharmaceuticals -- the World Leader in the Discovery and Development of Delta Receptor Compounds

NEW YORK, Aug. 12, 2004 (PRIMEZONE) -- Bioaccelerate, Inc. , a pharmaceutical development organisation has today announced that one of its portfolio companies, Enhance Biotech Inc (Pink Sheets:EBOI),...
August 12, 2004 10:53 ET | Source: Gardant Pharmaceuticals, Inc.

Bioaccelerate Portfolio Company Enhance Biotech to Merge with Privately-Held Ardent Pharmaceuticals -- the World Leader in the Discovery and Development of Delta Receptor Compounds

NEW YORK, Aug. 12, 2004 (PRIMEZONE) -- Bioaccelerate, Inc. , a pharmaceutical development organisation has today announced that one of its portfolio companies, Enhance Biotech Inc (Pink Sheets:EBOI),...

keyboard_arrow_left Previous Page